Weihe Zhang Ph.D (Ohio University)
Director, Medicinal Chemistry, BioCryst Discovery Center of Excellence, Birmingham, AL · United States
Editorial leadership for Journal of New Developments in Chemistry ISSN 2377-2549
Research interests
- Organic Synthesis
- Medicinal Chemistry
- Drug Discovery
Biography
Dr. Weihe Zhang is Director of Medicinal Chemistry at the BioCryst Discovery Center of Excellence in Birmingham, AL, United States. He earned his PhD from Ohio University and was originally trained as an organic chemist, with more than ten years of hands-on experience in synthetic chemistry. Dr. Zhang has over five years of experience in oncology therapeutic areas, focusing on the development of small molecules as novel therapeutic agents for the treatment of cancer. His most-cited publication, "Regioselective alkylation of a versatile indazole: Electrophile scope and mechanistic insights from density functional theory calculations" (2024), reflects his expertise in synthetic methodology and mechanistic understanding of organic transformations.
Selected publications
- Regioselective alkylation of a versatile indazole: Electrophile scope and mechanistic insights from density functional theory calculations 2024 cited 5×
- Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon 2022 cited 3×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JNDC for your work?
This journal is guided by Weihe Zhang (Director, Medicinal Chemistry, BioCryst Discovery Center of Excellence, Birmingham, AL) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.